Content by Beckman Coulter Diagnostics
|2 min read
FDA Clears AQUIOS STEM System for Stem Cell Analysis
Innovation Provides United States with First Workflow Update in 25 Years
|3 min read
FDA Emergency Use Authorization Awarded to the Beckman Coulter Access IL-6 Test
The Access Interleukin-6 (IL-6) assay is designed to assist physicians in the identification of severe inflammatory response in COVID-19 patientsPage 1 of 1
